Fertility-sparing surgery in uterine leiomyosarcoma

Area of Science:

• Gynecologic Oncology
• Reproductive Endocrinology
• Surgical Pathology

Background:

• Uterine leiomyosarcoma is a rare cancer with a poor prognosis, typically treated with hysterectomy.
• Diagnosis can occur post-myomectomy, leaving conservative management options undefined for young patients.
• Conservative approaches are not well-established for nulliparous women desiring future fertility.

Purpose of the Study:

• To evaluate the safety and outcomes of conservative management for uterine leiomyosarcoma diagnosed after myomectomy in young, nulliparous women.
• To assess the feasibility of fertility preservation in selected cases of uterine leiomyosarcoma.
• To determine the necessity of strict follow-up protocols in conservatively managed uterine leiomyosarcoma.

Main Methods:

• Retrospective analysis of eight patients with uterine leiomyosarcoma post-myomectomy, conservatively managed between 1982-1996.
• Patients were young (median age 29), nulliparous, and informed of risks.
• Strict surveillance included pelvic exams, hysteroscopy, imaging (ultrasound, CT/MRI), and chest X-rays.

Main Results:

• Three pregnancies occurred during follow-up (median 42 months); two resulted in term deliveries.
• One patient developed recurrent disease during cesarean section, succumbing to disseminated disease.
• Seven patients remain disease-free; two underwent further surgery for presumed leiomyomas.

Conclusions:

• Conservative management may be suitable for select young, nulliparous women with uterine leiomyosarcoma who wish to preserve fertility.
• Rigorous, long-term follow-up is essential for monitoring recurrence and disease progression.
• Hysterectomy can be considered after completion of childbearing in these selected cases.